We are live on ! Find out more
CTKB icon

Cytek Biosciences
CTKB

84 hedge funds and large institutions have $568M invested in Cytek Biosciences in 2022 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 36 increasing their positions, 17 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

112% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 17

86% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 14

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

14% more funds holding

Funds holding: 74 → 84 (+10)

10% more capital invested

Capital invested by funds: $515M → $568M (+$53.3M)

3.78% more ownership

Funds ownership: 35.59% → 39.37% (+3.8%)

Holders
84
Holders Change
+10
Holders Change %
+13.51%
% of All Funds
1.42%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
26
Increased
36
Reduced
17
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BWLSA
Blue Water Life Science Advisors
California
+$20.9M
2
BlackRock
BlackRock
New York
+$10.4M
3
RI
RTW Investments
New York
+$9.13M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$9.01M
5
Millennium Management
Millennium Management
New York
+$7.81M

Top Sellers

Rank Fund Capital Flow
1
MGM
Miura Global Management
New York
-$6.03M
2
Goldman Sachs
Goldman Sachs
New York
-$5.72M
3
Two Sigma Investments
Two Sigma Investments
New York
-$5.65M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$5.21M
5
Bank of America
Bank of America
North Carolina
-$2.17M
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
RA Capital Management
Massachusetts
$144M – – –
HA
2
HHLR Advisors
Cayman Islands
$94M – – –
BlackRock
3
BlackRock
New York
$76.6M +$10.4M +1,044,052 +17%
Vanguard Group
4
Vanguard Group
Pennsylvania
$67.3M -$779K -78,288 -1%
BWLSA
5
Blue Water Life Science Advisors
California
$22.5M +$20.9M +2,100,000 New
State Street
6
State Street
Massachusetts
$18.5M +$4.03M +405,162 +31%
MGM
7
Miura Global Management
New York
$17.7M -$6.03M -605,600 -27%
Point72 Asset Management
8
Point72 Asset Management
Connecticut
$16.5M +$9.01M +905,079 +143%
Geode Capital Management
9
Geode Capital Management
Massachusetts
$12.3M +$2.23M +224,330 +24%
RI
10
RTW Investments
New York
$9.84M +$9.13M +916,838 New
Millennium Management
11
Millennium Management
New York
$9.68M +$7.81M +784,708 +666%
Northern Trust
12
Northern Trust
Illinois
$8.89M +$1.21M +121,153 +17%
Fidelity International
13
Fidelity International
Bermuda
$6.26M – – –
Fidelity Investments
14
Fidelity Investments
Massachusetts
$5.59M +$26K +2,616 +0.5%
GCM
15
Glenview Capital Management
New York
$5.37M +$4.43M +444,587 +802%
PVI
16
Pura Vida Investments
New York
$5.12M +$523K +52,587 +12%
N
17
Nuveen
North Carolina
$4.77M +$939K +94,356 +27%
Bank of New York Mellon
18
Bank of New York Mellon
New York
$3.52M +$614K +61,654 +23%
Charles Schwab
19
Charles Schwab
California
$3.38M +$253K +25,410 +9%
Ameriprise
20
Ameriprise
Minnesota
$2.96M +$2.75M +276,202 New
Citadel Advisors
21
Citadel Advisors
Florida
$2.84M +$2.38M +239,579 +945%
D.E. Shaw & Co
22
D.E. Shaw & Co
New York
$2.26M -$5.21M -523,254 -71%
Morgan Stanley
23
Morgan Stanley
New York
$2.11M +$784K +78,756 +67%
Renaissance Technologies
24
Renaissance Technologies
New York
$1.75M +$1.08M +108,600 +200%
Swiss National Bank
25
Swiss National Bank
Switzerland
$1.7M +$1.57M +158,100 New
1
2 3 4

CTKB Hedge Fund Activity: Q2 2022 in Review

84 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Cytek Biosciences (CTKB) for Q2 2022, worth a combined $568M — up 10% from $515M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new CTKB positions and 14 closed out — a net gain of 12 holders — while 36 added to existing stakes and 17 trimmed.

The largest buyer was Blue Water Life Science Advisors, opening a new position worth an estimated $20.9M. The largest seller was Miura Global Management, cutting an estimated $6.03M.

  • 84 institutional investors held Cytek Biosciences (CTKB) as of Q2 2022, up from 74 in Q1 2022.
  • Funds reported $568M of Cytek Biosciences stock for Q2 2022, up 10% quarter-over-quarter.
  • 26 funds opened new Cytek Biosciences positions in Q2 2022 and 14 closed out, a net change of +12 holders.
  • The largest Cytek Biosciences buyer in Q2 2022 was Blue Water Life Science Advisors, an estimated $20.9M added.
  • The largest Cytek Biosciences seller in Q2 2022 was Miura Global Management, an estimated $6.03M sold.

Based on aggregated 13F filings for Q2 2022.